State-of-the-Art Manufacturing Facilities

Our 15 manufacturing units are strategically located and equipped with cutting-edge technology, supporting a wide range of products across multiple therapeutic categories. Each facility is designed for optimal productivity, safety, and compliance, making Akums a pioneer in Contract Development and Manufacturing (CDMO). Our manufacturing plants are certified by leading global health authorities.

Our production units are categorized into dedicated sections for pharmaceuticals, nutraceuticals, herbal, and cosmetics, ensuring specialized handling and production according to the highest regulatory requirements.

Pharmaceuticals

Nutraceuticals

Ayurveda

Derma | Cosmetics

Manufacturing Facilities to Trust upon

Varied Production

Varied production lines for consistent quality assurance and efficiency.

Environmental Controls

Based on the dosage forms and product requirements, various environmental controls are in place.

Specialized Facilities

Specialized facilities are in place for sterile production, carbapenems, and female hormonal medicine manufacturing.

R&D Centers

Dedicated 4 R&D centers to ensure fastest and seamless technology transfer from development to production.

Large-Scale Manufacturing Capacity

Our vast production capacity enables Akums to handle both small-scale niche projects and large-scale global supply demands. With an annual production capacity of 49 billion units across all dosage forms, we ensure timely delivery and consistency in every batch.

47.78

Oral solids

744.20

Sterile

417.60

Liquids

158.40

Topicals

Versatile Dosage Form Capabilities

At Akums, we understand that different therapeutic categories and patient needs demand diverse dosage forms. Our facilities are equipped to handle a vast range of dosage forms, tailored to specific market needs and regulatory environments.

Tablets and Capsules

Immediate and controlled release tablets, multi-layered tablets, chewable tablets, sugar and film-coated tablets, in-lay tablets hard and soft gelatin capsules.

Liquid Orals

Syrups, suspensions, emulsions, solutions, drops, and tinctures, with advanced packaging in HDPE and PET bottles.

Injectables

Ampoules, vials, pre-filled syringes, lyophilized products, and infusions

Topical Formulations

Creams, ointments, gels, lotions, and sprays for dermatological and cosmetic applications.

Effervescent Tablets

High-quality effervescent formulations for nutraceuticals and pharmaceuticals, ensuring fast absorption and ease of consumption.

Herbal & Ayurvedic Products

GMP-certified production of ayurvedic tablets, oils, pastes, and powders.

Soft Gel Capsules

Encapsulation of oils, vitamins, and herbal extracts in soft gels, with customized packaging options.

Gummies and Chewables

With the rising demand for vegan, plant-based, and sugar-free alternatives, Akums leads in producing vegan-friendly gummies that meet market trends.

Connect with us to explore cutting-edge solutions and innovation

Comprehensive Quality Assurance and Compliance

Quality is at the core of everything we do. Our Quality Management System (QMS) ensures compliance with international standards from raw material procurement to finished product release. Every product batch undergoes extensive testing including:

In-process quality checks

Stability studies

Dissolution & disintegration testing

Heavy metal & impurity profiling

Our Regulatory Affairs team ensures all products meet global market requirements, facilitating registration, documentation, and audits for seamless international trade.

API Manufacturing and Research & Development Facilities

Manufacturing facilities with advanced capabilities, complemented by dedicated R&D laboratories for continuous innovation.

Dera Bassi

Dedicated to the production of beta lactams with six production blocks and an annual capacity of 557.00 MT. Enables complex multistep synthesis to meet high API demand.

Lalru

Designed for synthesizing a wide range of APIs across therapy areas. Features three production blocks with an annual capacity of 180.00 MT.

Barwala

Specialized small-volume, high-potency API unit with a kilo lab scale pilot plant. Annual capacity of 0.38 MT, focused on precision and expertise.

Dedicated Research and Development (R&D) Capabilities

Akums has one of the most advanced R&D infrastructures, with teams of experts in formulation development, analytical research, and process optimization.

New chemical entities (NCE)
Modified drug delivery systems
Novel dosage forms such as fast-dissolving tablets, sustained-release formulations, and multi-layer tablets
Technology transfers for seamless transition from development to production

We work in close collaboration with our clients to innovate and optimize formulations that provide better therapeutic outcomes while adhering to cost efficiency and market needs.

Our Business Partners

We collaborate with leading brands, providing comprehensive manufacturing solutions. Our dedication to innovation and quality strengthens long-term partnerships, helping businesses scale efficiently while maintaining superior product standards.

Flexible Engagement Models to Accelerate Growth and Market Entry

Adaptable business models that support rapid scaling and seamless expansion into new markets.

🤝 Technical Collaboration

💉 CRAMS

📘 Technology Transfer

📄 Loan License

🧪 Contract Development

Technical Collaboration & Joint Venture

Akums has successfully established technical collaborations and joint ventures, strengthening its position in the pharmaceutical industry. By partnering with leading global companies, Akums leverages shared expertise to develop and manufacture high-quality products. These partnerships enable access to advanced technologies, niche therapeutic areas, and global best practices, ensuring that our offerings remain competitive and future-ready.

Akums’ strategic alliances ensure the delivery of innovative solutions to address healthcare challenges, while fostering growth, competitiveness, and value creation for all stakeholders involved. We remain committed to exploring new synergies, expanding our global footprint, and setting new benchmarks in pharmaceutical excellence.

Contract Research & Manufacturing Services (CRAMS)

Akums CRAMS Services are specifically designed for pharmaceutical companies who need help with critical aspects of their drug development process, and regulatory compliance. Akums CRAMS Services has a strong focus on quality and regulatory compliance, so companies can be confident that their products will be manufactured to the highest standards. Akums CRAMS Services also offers a comprehensive suite of services, including pre-clinical research, regulatory consulting, clinical trials management, and clinical development.

With a commitment to innovation and operational excellence, Akums ensures seamless project execution from concept to commercialization. Our experienced team works as an extension of your organization, enabling faster timelines, reduced risks, and optimized outcomes in every stage of development.

Technology Transfer

Akums excels in technology transfer, a crucial aspect of the pharmaceutical industry. By sharing knowledge, processes, and proprietary technologies with partner organizations, Akums facilitates the successful implementation of innovations in drug development and manufacturing.

This collaborative approach ensures seamless scaling from lab to commercial production, maintaining high-quality standards and regulatory compliance. Through technology transfer, Akums not only helps partners reach their full potential but also contributes to advances in healthcare solutions for the betterment of patient outcomes worldwide.

Loan License

Akums offers loan licensing services, providing pharmaceutical companies access to its state-of-the-art manufacturing facilities and expertise. By entering into a loan license agreement, partners can efficiently produce their products without the need to invest in infrastructure and resources. Akums ensures adherence to good manufacturing practices (GMP), maintaining high-quality standards and regulatory compliance.

This mutually beneficial arrangement enables companies to focus on core competencies, such as research and development, while leveraging Akums’ manufacturing capabilities for enhanced productivity and market presence.

Contract Development

Contract Development is a critical part of our business model. Our contract development team is made up of highly qualified and experienced professionals with a proven track record of providing high quality results for our clients. All of our contract development services are customized to meet the specific needs and requirements of the client.

Akums provides an end-to-end solution for all aspects of contract development including drug development, clinical research, drug manufacturing etc.

Our Global Presence

In addition to our core CDMO business, we actively engage in marketing our own branded formulations across global markets, and have established an international presence through our subsidiary Unosource.

Our international presence extends across 60 countries, and our key clients include Allegens (Vietnam), Ambica International (Philippines), Caferma SAC (Peru), JDS (Myanmar), Master Pharma (Cambodia), Olainfarm (Latvia), Pharma Apex (Myanmar), Planet Pharmaceutical (Tanzania), and Unisel (Kenya), among others.

BUILD OR ENHANCE YOUR CURRENT SUPPLY WITH AKUMS

Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.